Gene · 716
Papers3,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 3,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-omics analysis reveals the interaction between the complement system and the coagulation cascade in the development of endometriosis. | Sci Rep | 2021 | 34099740 | PubTator, text mining | PubMed |
| Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response. | Proc Natl Acad Sci U S A | 2021 | 34099557 | PubTator, text mining | PubMed |
| Immune Thrombocytopenia: Recent Advances in Pathogenesis and Treatments. | Hemasphere | 2021 | 34095758 | PubTator, text mining | PubMed |
| Cellular Tropism of SARS-CoV-2 across Human Tissues and Age-related Expression of ACE2 and TMPRSS2 in Immune-inflammatory Stromal Cells. | Aging Dis | 2021 | 34094637 | PubTator, text mining | PubMed |
| Machine learning-assisted immune profiling stratifies peri-implantitis patients with unique microbial colonization and clinical outcomes. | Theranostics | 2021 | 34093848 | PubTator, text mining | PubMed |
| Tackling Chronic Kidney Transplant Rejection: Challenges and Promises. | Front Immunol | 2021 | 34093552 | PubTator, text mining | PubMed |
| Label-free quantitative proteomic analysis of serum extracellular vesicles differentiating patients of alcoholic and nonalcoholic fatty liver diseases. | J Proteomics | 2021 | 34089894 | PubTator, text mining | PubMed |
| Renal Handling of Albumin-From Early Findings to Current Concepts. | Int J Mol Sci | 2021 | 34071680 | PubTator, text mining | PubMed |
| Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis. | Int J Mol Sci | 2021 | 34071155 | PubTator, text mining | PubMed |
| Targeting the Complement Cascade in the Pathophysiology of COVID-19 Disease. | J Clin Med | 2021 | 34069355 | PubTator, text mining | PubMed |
| Molecular Basis of Complement C1q Collagen-Like Region Interaction with the Immunoglobulin-Like Receptor LAIR-1. | Int J Mol Sci | 2021 | 34066122 | PubTator, text mining | PubMed |
| Complement Components in the Diagnosis and Treatment after Kidney Transplantation-Is There a Missing Link? | Biomolecules | 2021 | 34064132 | PubTator, text mining | PubMed |
| Proteomic Exploration of Plasma Exosomes and Other Small Extracellular Vesicles in Pediatric Hodgkin Lymphoma: A Potential Source of Biomarkers for Relapse Occurrence. | Diagnostics (Basel) | 2021 | 34063765 | PubTator, text mining | PubMed |
| Complement Proteins as Soluble Pattern Recognition Receptors for Pathogenic Viruses. | Viruses | 2021 | 34063241 | PubTator, text mining | PubMed |
| C1q as a potential tolerogenic therapeutic in transplantation. | Am J Transplant | 2021 | 34058061 | PubTator, text mining | PubMed |
| Roles of Immune Cells in Hereditary Angioedema. | Clin Rev Allergy Immunol | 2021 | 34050913 | PubTator, text mining | PubMed |
| Urinary complement proteins and risk of end-stage renal disease: quantitative urinary proteomics in patients with type 2 diabetes and biopsy-proven diabetic nephropathy. | J Endocrinol Invest | 2021 | 34043214 | PubTator, text mining | PubMed |
| Complement C1s and C4d as Prognostic Biomarkers in Renal Cancer: Emergence of Noncanonical Functions of C1s. | Cancer Immunol Res | 2021 | 34039653 | PubTator, text mining | PubMed |
| LC-MS/MS analysis of lesional and normally looking psoriatic skin reveals significant changes in protein metabolism and RNA processing. | PLoS One | 2021 | 34038424 | PubTator, text mining | PubMed |
| Complement C1s cleaves PfEMP1 at interdomain conserved sites inhibiting Plasmodium falciparum cytoadherence. | Proc Natl Acad Sci U S A | 2021 | 34035177 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/716/papers?page=56